Federal and state dismissal agreements require Cornelius Aaron Pettus to resign and promise never to work in law enforcement anywhere else. A separate civil case continues.
The ALBORADA Drug Discovery Institute (ADDI) announced that it will collaborate with pharmaceutical company YD Global Life Science (YDGLS) to develop inhibitors of the unfolded protein response for the treatment of the diseases that cause dementia.